- , Stock Quote, Analysis, Rating and News"> - " />
Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

(RARX)

47.995   0 (0%) 09-29 10:09
Open: 47.99 Pre. Close: 47.995
High: 48 Low: 47.98
Volume: 3,864,670 Market Cap: 2,272M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: - -
Low: - -
Close: - -

Technical analysis

as of:
Overall:       
Target: Six months:     One year:
Support: Support1:    Support2:
Resistance: Resistance1:    Resistance2:
Pivot:
Moving Average: MA(5):     MA(20):
MA(100):     MA(250):
MACD: MACD(12,26):     Signal(9):
Stochastic oscillator: %K(14,3):     %D(3):
RSI: RSI(14):
52-week: High:   Low:   Change(%):
Average Vol(K): 3-Month:   10-Days:

Price, moving averages and Bollinger Bands


Headline News

Fri, 11 Sep 2020
Sep 11, 2020 - Ra Capital Management, Llc Buys Novavax Inc, Satsuma Pharmaceuticals Inc, Macrogenics Inc, Sells Ra Pharmaceuticals Inc, Exelixis Inc, Gilead Sciences Inc - GuruFocus.com

Wed, 01 Apr 2020
How Ra Pharmaceuticals (RARX) Stock Stands Out in a Strong Industry - Yahoo Finance

Thu, 10 Oct 2019
UCB Agrees to Acquire Ra Pharmaceuticals: Joining Forces to Improve Treatment Options for People Living With Myasthenia Gravis and Other Rare Diseases - Business Wire

Thu, 10 Oct 2019
SHAREHOLDER ALERT: WeissLaw LLP Investigates Ra Pharmaceuticals, Inc. - PRNewswire

Thu, 10 Oct 2019
Ra Pharma (RARX) Alert: Johnson Fistel Investigates Proposed Sale of Ra Pharmaceuticals; Is $48 a Fair Price? - PRNewswire

Thu, 10 Oct 2019
Ra Pharmaceuticals (RARX) to be Acquired by UCB at $48/Sh - StreetInsider.com

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 0
Shares Float (M) 0
% Held by Insiders
% Held by Institutions
Shares Short (K) 0
Shares Short P. Month (K) 0

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 0
Levered Free Cash Flow (M) 0

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date
Ex-Dividend Date
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.